ING5 regulates metabolic reprogramming in lung cancer cells

FHS
January 6, 2025
11:14 am

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes.

Racial and ethnic inequities are substantial in type 2 diabetes after gestational diabetes, study shows

Racial and ethnic inequities in diabetes have been established following gestational diabetes, but these inequities are substantial and have been an overlooked facet of maternal

September 8, 2023

Filament Health Announces Fda Approval Of Two Clinical Trials Studying Its Botanical Psilocybin Drug Candidate Pex010 | Psychedelic Finance

The University of Washington and the University of California, Los Angeles have been approved to study PEX010 in clinical trials for mental health conditions VANCOUVER,

August 10, 2023

AlphaFold, meet AlphaMissense: Google DeepMind’s AI successor predicts how 71M mutations cause disease

Google DeepMind has developed an AI system that predicts the chances that tens of millions of genetic variants will cause disease. Called AlphaMissense, the technology

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.